| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
01-24-2017, 01:11 PM
|
#1 | ||
|
|||
|
Member
|
The GU Alzheimer's trial for Nilotinib has begun recruiting. I anticipate the Parkinson's trial to get underway soon. This will be a single site study for patients living in the vicinity of GU. The multi site trial funded by MJFF et al will be led by Northwestern U. with 20 - 25 test sites throughout the country. That will likely get underway midyear.
|
||
|
 Reply With Quote
|
| "Thanks for this!" says: | Betsy859 (02-01-2017), eds195 (01-24-2017), jeffreyn (01-24-2017), lab rat (01-26-2017), Lana (01-24-2017), lurkingforacure (01-26-2017), RLSmi (01-27-2017), soccertese (01-25-2017), zanpar321 (01-24-2017) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Georgetown Receives FDA Clearance for Trial with Nilotinib in Alzheim | Parkinson's Disease | |||
| interesting - /patient-trial-of-immunization-to-treat-alzheimer-s-disease-begins-at-c | Parkinson's Disease | |||
| Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise | Parkinson's Disease | |||
| Pilot Clinical Trial: Insulin Therapy and Alzheimer's Disease | Alzheimer's Disease | |||
| DBS Trial Enrollment - Boston Scientific Begins Patient Enrollment in Clinical Trial | Parkinson's Disease Clinical Trials | |||
Georgetown Clinical Trial of Nilotinib in Alzheimer’s Disease Begins
Linear Mode
